Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-10-5
pubmed:abstractText
To evaluate anti-IgE (ie, omalizumab) efficacy on severe allergic asthma in order to achieve the efficacy of this treatment on severe allergic asthma progress by means of asthma control questionnaire (ACQ), asthma quality of life questionnaire (AQLQ) as well as pulmonary function (FEV1) and physician overall assessment.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0025-7753
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
133
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
460-3
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19775710-Adolescent, pubmed-meshheading:19775710-Adrenal Cortex Hormones, pubmed-meshheading:19775710-Adult, pubmed-meshheading:19775710-Aged, pubmed-meshheading:19775710-Anti-Asthmatic Agents, pubmed-meshheading:19775710-Antibodies, Anti-Idiotypic, pubmed-meshheading:19775710-Antibodies, Monoclonal, pubmed-meshheading:19775710-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19775710-Asthma, pubmed-meshheading:19775710-Data Interpretation, Statistical, pubmed-meshheading:19775710-Female, pubmed-meshheading:19775710-Humans, pubmed-meshheading:19775710-Male, pubmed-meshheading:19775710-Middle Aged, pubmed-meshheading:19775710-Quality of Life, pubmed-meshheading:19775710-Questionnaires, pubmed-meshheading:19775710-Skin Tests, pubmed-meshheading:19775710-Time Factors, pubmed-meshheading:19775710-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
[Analysis of asthma control and quality of life in severe allergic asthmatics under treatment with anti-IgE, omalizumab].
pubmed:affiliation
Servicio de Neumología, Hospital Ramón y Cajal, Madrid, Spain. apacheco.hcr@salud.madrid.org
pubmed:publicationType
Journal Article, Comparative Study, English Abstract